Quote To Start The Day: "Turn a perceived risk into an asset.”
Source: Aaron Patzer
One Big Thing In Fintech: AI and machine learning might amplify patterns of historical discrimination and financial exclusion through reliance on flawed data or mistakes in development.
Source: Roll Call
Other Key Fintech Developments:
- FIS head sees trading regulation.
- CBDCs: The good, bad, and ugly.
- Zerion integrates Gelato Network.
- HSBC created a fintech VC arm.
- Robinhood shrunk PFOF reliance.
- Kredivo announced SPAC plans.
- Figure, Homebridge are merging.
- Experian eyeing fraud protection.
- Mako secures $2M seed funding.
- Bakkt, Quiznos partner on crypto.
- Sigo Seguros launched in Texas.
- Public and Commonwealth team.
- Symphony has added StreetLinx.
- Jump makes a crypto acquisition.
- dYdX launches governance token.
- Dave shifts to virtual-first model.
- ChangeFi crafting fintech vision.
- KlariVis added engineers, talent.
- PagoNxt is expanding in Europe.
- ZenLedger raises $6M Series A.
- BlueVine adds insurance offering.
- Rapyd secured $300M in funding.
- India’s BharatPe valued at $2.9B.
Watch Out For This: New York City will become the first U.S. city to require proof of at least one dose of a coronavirus vaccine for a variety of activities for workers and customers — indoor dining, gyms and performances — to put pressure on people to get vaccinated, Mayor Bill de Blasio announced Tuesday morning.
Source: New York Times
Interesting Reads:
- Spirit, American Air cancel flights.
- TheVentureCity adds new partner.
- Netflix show on SpaceX to come.
- Goldman boosting junior salaries.
- Chairish bought Pamono market.
- Boeing tries 2nd spacecraft demo.
- Substack hones in on free speech.
- Nikola cuts semi delivery outlook.
- Cuomo probe finding harassment.
Market Moving Headline: China’s regulatory clampdown on industries such as tutoring and tech has unnerved global investors. We see little global spillover risk from China’s assertion of greater control over certain industries, even as it potentially leads to market volatility. We remain tactically neutral on China stocks and see further monetary and fiscal policy loosening as beneficial for cyclical assets in China.
Source: BlackRock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Your update on what’s going on in the Fintech space. Keep up-to-date with news, valuations, mergers, funding, and events. Sign up today!